Med-tech firms raising money in public or private financings, including: CAPS Medical, DNA Script, Eargo, Omega Therapeutics, Sema4.

New hires and promotions in the med-tech industry, including: Cartessa Aesthetics, Tandem Diabetes Care, Tearlab, Transcat, Zeteo Tech.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Emmaus, Inovio, Melt, Merck, Novartis, Regulus, Relief, Ridgeback, Roche, Scynexis, Teva.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aeterna Zentaris, Afecta, Amgen, Arrowhead, Atsena, Avacta, Biomed Valley Bolt, Catalent, Celonic, Cortexyme, Daewoong, Editas, Fortress, GSK, Heat, Horizon, Innate, Intravacc, La Jolla, Merck, Moderna, Motif, Piramal, Pfizer, Regeneron, Sanofi, Stata, Tetraphase, Truebinding, Zenith.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Auris, Constant, Denali, Dimerix, Genentech, Krystal, Repare, Samus, Sanofi.

Biopharmas raising money in public or private financings, including: Annexon, Arcturus, Atsena, Bioxcel, Essa, Inhibrx, Omega, Sunesis, TCR2, Trobix, Vico.

Quarterly snapshots from biopharma companies with marketed products, including: Alkermes, Amgen, United Therapeutics.

New hires and promotions in the biopharma industry, including: Alentis, Engrail, La Jolla, Omass.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Arcturus, Beigene, Can-Fite, Celltrion, Diffusion, Generex, Genor, Inotrem, Kyowa Kirin, Mesoblast, Neoimmunetech, Redhill.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.